Arthur 'Blaine' Bowman (born 1946 in Ogden, Utah, USA) is a leading proponent of ion chromatography, who has served variously as chairman, president, chief executive officer, and director of Dionex Corporation, a manufacturer of analytical instruments.

[1] In 1977, Bowman joined International Plasma Corporation of Hayward, California as chief financial officer and general manager of its analytical instrument division.

The IC division was spun off as a separate company, under the name Dionex Corporation, in a leveraged buyout (LBO) led by A. Blaine Bowman.

Bowman recognized the importance of developing software and data handling capabilities in support of Dionex's hardware.

"[6] Through such improvements, Dionex was able to support much faster extraction of organic compounds for analysis from chemical mixtures, including complicated samples such as soils, polymers, and processed foods.

The technology has wide application, in environmental testing laboratories, life science and food companies, chemical/petrochemical firms, power generation facilities, electronics manufacturers, government agencies, and academic institutions.

[8] The Environmental Protection Agency has approved instruments such as the Dionex AS4 column for the analysis of anions in drinking water.

[13] Bowman has served on the boards of directors of a number of companies in the areas of innovative technologies and the life sciences in addition to Dionex.

[10] In 2006, he was appointed lead director of the board of Cell BioSciences, a privately held company engaged in protein research in the emerging area of nanoproteomics.

[16] Solexa, which developed genome sequencing technology, was acquired in 2007 by Illumina, Inc., on whose board of directors Bowman now serves.